splicesitefinder like (Sophia Genetics)
Sophia Genetics is a verified supplier 
Sophia Genetics manufactures this product 
97
Structured Review
Sophia Genetics
splicesitefinder like
Splicesitefinder Like, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1558 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alamut%E2%84%A2+visual+plus/Alamut+Visual+Plus/pm42897219-82-11-15
Average 97 stars, based on 1558 article reviews
Splicesitefinder Like, supplied by Sophia Genetics, used in various techniques. Bioz Stars score: 97/100, based on 1558 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alamut%E2%84%A2+visual+plus/Alamut+Visual+Plus/pm42897219-82-11-15
Average 97 stars, based on 1558 article reviews
splicesitefinder like - by Bioz Stars,
2026-11
97/100 stars
Images
Related Articles
In Silico:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Oligomer Restriction:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Software:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Variant Assay:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Functional Assay:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Generated:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Whole Complete genome sequencing:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Mutagenesis:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using Sequencing:Article Title: Genetic testing considerations for hereditary duodenopancreatic neuroendocrine tumors Article Snippet: variant (LBV); class 3: variant of uncertain significance (VUS); class 4: likely pathogenic variant (LPV); or class 5: pathogenic variant (PV). Computational and population data were aggregated using |